Diamond Biofund is a venture capital firm that specializes in investing in early-stage life science companies. The firm focuses on providing capital and strategic support to innovative startups in the biotechnology, pharmaceuticals, and healthcare sectors.

Diamond BioFund is the largest fund dedicated to biotechnology innovation, managing assets worth over 260 million USD. We are also the first evergreen fund in Taiwan, assisting our venture partners to grow continuously. With renowned shareholders including a Fortune 500 enterprise and major financial holding companies in Taiwan, Diamond BioFund is led by an experienced management team with professionals from various backgrounds such as biotech, financial services, and academia, supporting our venture partners with practical knowledge in development and management. Driven by innovation excellence and operation efficiency, Diamond BioFund is committed to becoming the leading biotech venture fund in Taiwan and the global community.

Diamond BioFund currently focuses on healthcare and biotech related industry, including new drugs development, medical devices, health supplements, diagnostics, healthcare retailing channels, and innovative healthcare services. Our investment targets early stage innovative technology with global cutting edge impact. Leveraging the boom in China’s healthcare market, we also target valuable assets in the Greater China region.

COM:DIAMONDBIOFUND

Diamond Biofund

Analysis Not Available